The Alberta Cancer Foundation, Cancer Care Alberta, Merck, and Astra Zeneca have joined forces to launch the Precision Analytics program, a groundbreaking initiative aimed at revolutionizing cancer care in Alberta.

By leveraging advanced data analytics, the program seeks to address pressing challenges such as wait times and resource allocation, ultimately striving for better outcomes for patients and frontline medical staff.

“We know that cancer rates are increasing, putting constraints on the day-to-day workloads of healthcare providers and the system as a whole,” says Wendy Beauchesne, CEO, of the Alberta Cancer Foundation.

“It is paramount we address growing pressures facing the cancer care system today, so we are prepared to help those who need it tomorrow. Not only does the Precision Analytics program exemplify the power of collaboration, but it will create innovative strategies to reduce wait times and enhance capacity within our healthcare system.”

Brenda Hubley, chief program officer of Cancer Care Alberta expressed that by leveraging real-time data and cutting-edge analytics, they can improve the operations and ensure that patients with cancer receive timely access to high-quality care.

"The Precision Analytics program will provide us with invaluable insights into patient characteristics, trends, and resource allocation strategies," said Hubley. 

Through collaboration and innovation, this partnership represents a significant step forward in enhancing cancer care and supporting better health outcomes for Canadians affected by cancer.

Send your news tips, story ideas, pictures, and videos to